Table 2.

Laboratory features of patients with ATL

	WBC	ALC	CD4+ CD25+	IL-2R alpha	Hypercalcemia
1	3,300	1,016	302	9,434	No
2	2,840	826	257	1,528	Yes
3	5,080	1,158	595	1,567	No
4	2,790	625	90	6,329	No
5	6,000	1,157	203	1,039	No
6	11,000	101	772	4,880	Yes
7	6,100	793	1,061	29,780	No
8	5,450	763	162	3,940	No
9	10,800	194	367	20,630	No
10	3,200	1,024	246	5,872	No
11	3,760	1,339	581	1,461	No
12	5,470	1,597	1,076	18,178	No
13	49,300	38,701	40,640	1,627	No
14	19,200	1,536	6,994	16,324	Yes
15	111,000	98,790	13,768	30,500	Yes
16	48,000	31,959	36,201	61,137	No
17	63,000	40,128	4,834	23,580	No
18	6,000	26,818	1,486	1,240	Yes
19	271,000	252,030	213,339	2,935	Yes
20	35,700	23,562	26,595	18,000	Yes
21	225,000	204,750	193,571	41,230	Yes
22	2,830	1,007	519	3,633	No
23	26,400	13,200	12,457	44,530	Yes
24	64,500	41,280	53,261	<1,125	No
25	339,000	332,050	296,913	8,015	Yes
26	99,650	20,930	167	3,633	No
27	4,660	559	224	3,975	No
28	6,270	3,950	2,099	<1,135	No
29	3,540	1,841	27	855	No
Mean	49,684	39,487	31,338	6,329
Median	6,270	1,597	1,061	13,650
Range	2,790-339000	101-332050	27-296913	855-61,137*

• Does not reflect that values below <1125 or <1135 are not known with certainty